The South and Central America tissue processing systems market is expected to reach US$ 28.19 million by 2027 from US$ 20.48 million in 2019; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027.
The market growth is mainly attributed to the rising prevalence of cancer and increasing number of diagnostic laboratories in South and Central America. However, the high cost of cancer diagnostics restricts the Tissue processing systems market growth.
Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. According to a report presented by the International Cancer Research Center (IARC) at Globocan 2016, 20% of men and women in Argentina develop some type of cancer during their life. Thus, the increasing prevalence of cancer is likely to boost the demand for tissue processors in cancer diagnosis in the coming years. Also, the growing network of diagnostic laboratories across Latin America is favoring the growth of the market in this region.
The impact of COVID-19 pandemic on the tissue processing systems market in South and Central America has been minor in the last year. Restrictions on cross-border trade in several countries worldwide were the key factors that disrupted the supply and demand of tissue processing products. However, in the long run, the South and Central America market is expected to grow at a steady rate, owing to the precautions taken during the tissue processing system.
South and Central AmericaTissue processing systemsMarketRevenue and Forecast to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
South and Central AmericaTissue processing systems MarketSegmentation
By Product
- Tissue transfer processors
- Fluid transfer processors
By Volume
- Small volume processors
- Medium volume processors
- Large volume processors
By End User
- Hospitals
- Pharmaceutical companies
- Research laboratories
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD
- Agilent Technologies, Inc
South and Central America Tissue Processing Systems Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 20.48 Million |
Market Size by 2027 | US$ 28.19 Million |
Global CAGR (2020 - 2027) | 4.3% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
|
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















